SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (3432)11/23/1999 3:50:00 PM
From: Land Shark  Read Replies (1) | Respond to of 4140
 
Oh great, here comes another shorting op.



To: Joe who wrote (3432)11/23/1999 5:46:00 PM
From: BostonView  Read Replies (2) | Respond to of 4140
 
Sounds encouraging, Joe. I'll take this to mean, based on discussions with the FDA, SNRS feels very confident they have suitable (2 year) data for the ODP? Assuming they get the panels' blessing, do you know what diopter range SNRS will go to the FDA for? Also, is the two eye/same day procedure included in this round for panel revue and subsequent FDA determination? Thanks.

BV


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News